Re-imagining cardio-vascular systems performance
Dr Chris Crockford
BSC. MSc. MBA. PhD. MIEEE. MACM. MBCS. AFRMet. ARAeS. FRGS. FRA
YourHeartCheck.com was founded by Dr Chris Crockford. He is a PhD doctor not a Medical Doctor.
Having had the experience of taking part in two rounds of European Space Agency Astronaut selection, he has challenged his knowledge, skills and physiology more than most.
He was one of the few candidates to be selected by ESA in 2008 and again in 2021, making the last 1362 applicants from 23,307.
Building on his extensive experience from Formula1, he gained a ground breaking insight into human telemetry, build from scrupulous testing, track side analysis and reporting.
Chris became interested in human physiology after taking part in the Cauldwell Extreme Everest expedition in 2007.
During the expedition he would meet Professor Hugh Montgomery, Mr Mark Watson and Dr Sundeep Dhillon as he took part as a test subject, being tested daily for his physiological performance at altitude as he ascended up to Everest Base Camp and beyond.
For the 2008 through 2010 Chris worked as Business Development Director for McLaren F1, working across the business units of the McLaren Group.
In between works on protecting the IP of various race car suspension components and working on the development of telemetry systems, he furthered his interest in human physiology and performance, working with team doctor Aki Hintsa to fully comprehend the circadian rhythm cycle and its impact.
He was the named inventor on multiple patents for McLaren, exploiting the tacit knowledge within Formula 1 regarding telemetry and electronic data systems capture and its applicability to human telemetry and performance.
Chris left McLaren to exploit some new sensor technologies and developed a new medical device which could enable mass screening for the detection of Atrial Fibrillation, one of the leading causes of stroke, in mass populations.
He took the device from sensors and concept through to engineering and development and on to certification as a class 2a medical device.
He has published on the subject of proactive mass screening for cardiac arrhythmias in multiple journals and conference papers, and led the UK SLAF2 trial, developing the next generation of cardio and vascular performance monitoring.